| Literature DB >> 36053659 |
Nicola Firman1, Marta Wilk2, Gill Harper2, Carol Dezateux2.
Abstract
BACKGROUND: Children with obesity at school entry are at increased risk of persistent obesity throughout childhood and adulthood. Little is known about associations with adverse health outcomes with onset during childhood including those affecting the musculoskeletal system. We examined the association between obesity present at school entry and adverse musculoskeletal diagnoses with onset during childhood.Entities:
Keywords: Epidemiology; Health services research; Obesity
Mesh:
Year: 2022 PMID: 36053659 PMCID: PMC9358947 DOI: 10.1136/bmjpo-2022-001528
Source DB: PubMed Journal: BMJ Paediatr Open ISSN: 2399-9772
Characteristics of existing systematic reviews
|
|
|
|
|
|
|
|
|
|
| Paulis | 2014 | 0 to 18-year olds | 1 106 675 children in cross-sectional; 2380 in prospective | 40 | 33 cross-sectional, 7 prospective | Any definition of overweight or obesity between ages 0 and 18 years | Musculoskeletal pain, injury or fracture | Included studies are of moderate or low quality. |
| Stolzman | 2015 | 3 to 18-year olds | 835 350 children | 13 | Cross-sectional | Overweight or obesity between ages 3 and 18 years | Pes planus and other foot structure deformities | Only cross-sectional. |
Search strategy
|
|
|
| Population | Children aged five to 19 years (inclusive) |
| Intervention (exposure) | Children with obesity measured at school entry (approximately age 5 years) |
| Comparator | Children with a healthy weight at school entry (approximately age 5 years) |
| Outcome | Any self-reported, parent-reported, objectively measured or clinical diagnosis of an adverse musculoskeletal health outcome between the ages of 5 and 20 years, found to be statistically associated with the exposure. |
Figure 1 –Study selection
Study characteristics
|
|
|
|
|
|
|
|
| |||||
| Scotland | 597 017 children | Age 5–6 to 18 years, diagnosis of SCFE or censor date (December 2016) | Age-specific and sex-specific BMI standardised to UK90 reference population | Diagnostic record of SCFE (ICD10 M93.0 or ICD9 732.2) in linked hospital admission records | Adjusted IRR for SCFE was: 5.9 (3.9, 9.0) among those with severe obesity, 3.8 (2.6, 5.8) among those with mild/moderate obesity, 1.5 (0.9, 2.3) among those with overweight |
|
| |||||
| Madrid, Spain | 1884 children | Age 4 to 6 years | Age-specific and sex-specific BMI standardised to WHO 2006 reference tables | Visits to doctor offices relating to musculoskeletal system coded using International Classification of Primary Care −2 Classification | Adjusted IRR for musculoskeletal complaints: 1.3 (1.0,1.6) among children with abdominal obesity based on waist-to-height ratio, compared with children with no abdominal obesity |
|
| |||||
| Catalonia, Spain | 466,997 children | Age 4 to 15 years, migration out of area, death or censor date (2016) | Age-specific and sex-specific BMI standardised to WHO 2007 guidance | Lumbar spine pain (ICD-10: M54.1, M54.3, M54.4, M54.5) thoracic back pain (M54, M54.6, M54.8, M54.9) or cervical spine pain (M54.2) recorded in paediatric primary care clinics | Cumulative incidence of any back pain by weight status: 8.8% (8.5, 9.1) normal weight, 10.1% (8.9, 11.4) overweight, 11.8% (9.4,14.2) obese |
|
| |||||
| Catalonia, Spain | 466 997 children | Age 4 to 15 years, migration out of area, death or censor date (2016) | Age-specific and sex-specific BMI standardised to WHO 2007 guidance | Fractures recorded using Interntional Classification of Diseases-10 codes in primary care | Cumulative incidence for fracture by weight status: 10.1% (9.8, 10.3) normal weight, 11.3% (10.2, 12.4) overweight, 13.1% (10.7, 15.4) obese |
BMI, body mass index; IRR, incidence rate ratios; SCFE, slipped capital femoral epiphysis.
Risk of bias/quality assessment
|
|
|
|
|
|
| 1.1. Was the research question or objective in this paper clearly stated? | Yes | Yes | Yes | Yes |
| 2.2. Was the study population clearly specified and defined? | No | Yes | Yes | Yes |
| 3.3. Was the participation rate of eligible persons at least 50%? | Yes | Yes | CD | Yes |
| 4.4. Were all the subjects selected or recruited from the same or similar populations (including the same time period)? Were inclusion and exclusion criteria for being in the study prespecified and applied uniformly to all participants? | Yes | Yes | Yes | Yes |
| 5.5. Was a sample size justification, power description, or variance and effect estimates provided? | No | No | No | No |
| 6.6. For the analyses in this paper, were the exposure(s) of interest measured prior to the outcome(s) being measured? | Yes | Yes | Yes | Yes |
| 7.7. Was the timeframe sufficient so that one could reasonably expect to see an association between exposure and outcome if it existed? | Yes | No | Yes | Yes |
| 8.8. For exposures that can vary in amount or level, did the study examine different levels of the exposure as related to the outcome (eg, categories of exposure, or exposure measured as continuous variable)? | Yes | Yes | Yes | Yes |
| 9.9. Were the exposure measures (independent variables) clearly defined, valid, reliable and implemented consistently across all study participants? | No | Yes | Yes | Yes |
| 10.10. Was the exposure(s) assessed more than once over time? | No | No | No | No |
| 11.11. Were the outcome measures (dependent variables) clearly defined, valid, reliable and implemented consistently across all study participants? | Yes | No | Yes | Yes |
| 12.12. Were the outcome assessors blinded to the exposure status of participants? | NA | NA | NA | NA |
| 13.13. Was loss to follow-up after baseline 20% or less? | Yes | CD | Yes | CD |
| 14.14. Were key potential confounding variables measured and adjusted statistically for their impact on the relationship between exposure(s) and outcome(s)? | Yes | Yes | Yes | Yes |
| NF rating (good, fair or poor) | Good | Fair | Good | Good |
| MW rating (good, fair or poor) | Fair | Good | Good | Good |
| Overall rating (good, fair or poor) | Fair | Fair | Good | Good |
| Additional comments (if poor, state why) | BMI measurement protocol lacked detail | Short follow-up | Unable to determine participation rate | Unable to determine loss to follow-up |
BMI, body mass index; CD, cannot determine; NA, not applicable.
Figure 2 –Forrest plot of incident rate ratios and HRs (and 95% CIs) for adverse musculoskeletal outcome of interest, by weight status. This graph uses weight status terms employed by the study authors.1 Perry et al defined obesity using age-specific and sex-specific body mass index criteria of the Centers for Disease Control and Prevention, defining obesity as BMI greater than or equal to the 95th percentile, and further stratified obesity into mild/moderate (≥95th–<99th percentile) and severe (99th percentile). Sample size in the mild/moderate and severe obesity groups were not reported.2 Incident rate ratio.3 Slipped capital femoral epiphysis.4 Ortiz-Pinto et al defined obesity based on body mass index SD) score using WHO age-specific and sex-specific growth standards to define obesity as body mass index z-score ≥2SD scores. Abdominal obesity was defined as waist circumference ≥90th percentile and waist-to-height ratio ≥ 90th percentile, as recommended by the International Diabetes Federation.5 Palmer et al and Lane et al defined obesity based on body mass index SD score using WHO age-specific and sex-specific growth standards to define obesity as body mass index z-score ≥3SD scores.6 HR.7 95% CI.